Filed with ASX · · 10 pages · English
HeraMED Ltd has released its Quarterly Activities and Cashflow Report for the September quarter, detailing significant advancements in its US commercialisation strategy, particularly with Lee Health's full deployment of the Digital Pregnancy Journey. The report highlights a secured initial contract with Lee Health, marking a transition from pilot to paid deployment, and outlines ongoing integration efforts with Epic EMR to enhance scalability. Additionally, the company reported a strengthened cash position and a disciplined approach to managing operating expenditures while pursuing further commercial opportunities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ASX ANNOUNCEMENT 30 OCTOBER 2026 QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C SEPTEMBER 2026 QUARTER Q3 FY26 HIGHLIGHTS • Lee Health commercial rollout commenced: Transitioned from pilot phase to paid, commercial deployment within a major US health system delivering over 8,000 babies annually. •...
